TerrAscend

Overview
Activities
News
Cannabis?
Product stageSegments
Expansion
?
Cultivators, Dispensaries, Extractors and infusers
?

TerrAscend is a leading North American cannabis operator with vertically integrated operations in California, Maryland, Michigan, New Jersey, and Pennsylvania, as well as retail operations in Canada. The company focuses on growing high-quality cannabis, promoting its health benefits, and offering a diverse range of products tailored to the needs of medical patients and adult-use consumers. TerrAscend utilizes advanced cultivation techniques, innovative cannabis cultivars, and strategic technology investments to produce premium cannabis products.

In March 2022, TerrAscend completed the acquisition of Gage Growth Corp., a prominent cannabis brand and operator, in a deal valued at over USD 545 million. This strategic acquisition aimed to create a differentiated and compelling player in the North American cannabis market, combining TerrAscend's proven cultivation and manufacturing expertise with Gage's top-selling brands and exceptional retail experiences.

As of January 2023, TerrAscend operated 32 dispensaries nationwide under its award-winning retail concepts, The Apothecarium and Gage. The company's portfolio includes several synergistic businesses and brands, such as Gage Cannabis, Ilera healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. In May 2023, TerrAscend strengthened its balance sheet by selling a facility in Canada for CADUSD 19.7 million, using the proceeds to pay down existing debt.

Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
L5B 4A7 Mississauga ON CAN
Founded year:
2017
Employees:
1,001-5,000
IPO status:
Public
Total funding:
USD 581.3 mn
Last Funding:
USD 140.0 mn (Post IPO Debt; Aug 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.